We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Pancreatic cancer patients treated with ViewRay’s MRIdian ablative radiation technology had a one-year survival rate from diagnosis of 93.9 percent and no incidences of acute toxicity, according to study results reported at the annual meeting of the American Society for Radiation Oncology (ASTRO) in San Antonio, Texas, Oct. 24-27. Read More
Becton Dickinson (BD) and Magnolia Medical have teamed up to market the companies’ complementary blood collection devices in an effort to reduce contamination of blood samples collected from suspected sepsis patients. Read More
Apple has filed a lawsuit against Delaware-based medical device developer Masimo, alleging that the company infringed upon numerous Apple Watch patents with its new W1 smartwatch line. Read More
An FDA advisory panel has voted 11-2 against approval of SOLVD Health’s De Novo request to market AvertD, a genotype test to identify patients at increased risk of opioid use disorder (OUD). Read More
The FDA’s biggest challenge in protecting medical devices from cybersecurity breaches is legacy technology, says a top agency technology official. Read More
The FDA handed Akron Coating & Adhesives a Form 483 for not properly testing or controlling combination drug-device products at its Akron, Ohio, facility. Read More
The FDA has issued a warning letter to Forcemech International in Pearland, Texas, after not getting a response to observations it made during an inspection from March 29 to April 4. Read More